Shares of Bruker Corp. (BRKR) plummeted as much as 5.86% in pre-market trading on Monday, following the release of the company's third-quarter 2024 financial results.
The scientific instruments and analytical solutions provider reported adjusted earnings per share of $0.60 for the quarter, narrowly beating analysts' expectations of $0.59. However, revenue of $864.4 million, while surpassing the consensus estimate of $859.4 million, fell short of investors' expectations.
More concerning, Bruker's full-year 2024 revenue guidance range of $3.34 billion to $3.37 billion fell below the analyst consensus of $3.40 billion, indicating potential headwinds or weak demand in the company's core markets.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.